2 tables omitted
Vaccination of persons at risk for complications from influenza and
pneumococcal disease is a key public health strategy for preventing associated
morbidity and mortality in the United States. Risk factors include older age
and medical conditions that increase the risk for complications from infections.
During the 1990-1999 influenza seasons, more than 32,000 deaths each year
among persons aged ≥65 years were attributed to complications from influenza
infection.1 National health objectives for 2010 call for 90% influenza
and pneumococcal vaccination coverage among noninstitutionalized persons aged
≥65 years and 60% coverage among noninstitutionalized persons aged 18-64
years who have risk factors (e.g., diabetes or asthma) for complications from
infections2 (objective nos. 14.29a–d). To estimate influenza
and pneumococcal vaccination coverage among these populations, CDC analyzed
data from the 2003 Behavioral Risk Factor Surveillance System (BRFSS) survey.*
This report summarizes the results of that analysis, which indicated that
(1) influenza vaccination levels among adults aged 18-64 with diabetes or
asthma, (2) pneumococcal vaccination levels among adults aged 18-64 years
with diabetes, and (3) influenza and pneumococcal vaccination levels among
adults aged ≥65 years all were below levels targeted in the national health
objectives for 2010. Moreover, vaccination coverage levels varied among states
for both vaccines and both age groups. Innovative approaches and adequate,
reliable supplies of vaccine are needed to increase vaccination coverage,
particularly among adults with high-risk conditions.
BRFSS is a state-based, random-digit–dialed telephone survey of
the U.S. civilian, noninstitutionalized population aged ≥18 years. All
50 states, the District of Columbia (DC), and three U.S. territories participate
in the survey. Respondents were asked, “During the past 12 months, have
you had a flu shot?” and “Have you ever had a pneumonia shot?”
Persons with diabetes were defined as respondents who answered “yes”
to the question, “Have you ever been told by a doctor that you have
diabetes?” Women who were told that they had diabetes only during pregnancy
were not defined as having diabetes. Participants were also asked, “Have
you ever been told by a doctor, nurse, or other health professional that you
had asthma?” Those who responded “yes” were then asked,
“Do you still have asthma?” Respondents who answered affirmatively
to both questions were classified as having asthma. For the 2003 BRFSS, the
median state/area response rate was determined to be 53.2% (range: 34.4%-80.5%)
by using the CASRO method. A total of 266,346 persons responded, of whom 207,735
(83.0%) were aged 18-64 years and 56,547 (17.0%) were aged ≥65 years. Among
respondents aged 18-64 years, 17,084 (7.8%) reported having asthma and 12,412
(5.7%) reported having diabetes. Respondents with unknown influenza (0.3%)
or pneumococcal (7.0%) vaccination status were excluded from the analysis.
Vaccination levels were estimated for the 50 states, DC, Guam, Puerto Rico,
and the U.S. Virgin Islands (USVI). Data were weighted by age, sex, and, in
certain states/areas, race/ethnicity to reflect the estimated adult population.
Statistical software was used to calculate point estimates and 95% confidence
In 2003, of respondents aged ≥65 years, influenza vaccination coverage
levels during the preceding 12 months ranged from 34.9% (USVI) to 80.3% (Minnesota),
with a median of 69.9%. Among respondents aged ≥65 years, the proportion
reporting ever having received pneumococcal vaccine ranged from 31.6% (USVI)
to 73.0% (Minnesota), with a median of 64.2%. Compared with 2002, a total
of 41 and 38 states/areas experienced increases in influenza and pneumococcal
coverage among those aged ≥65 years, respectively; 11 of these increases
were statistically significant for each vaccine.
Among adults aged 18-64 years with asthma or diabetes, substantial variation
in vaccination coverage by area also was observed. For respondents with asthma,
median influenza coverage was 34.0% and ranged from 22.5% (Puerto Rico) to
46.6% (Wyoming). Influenza vaccination rates among persons with asthma were
higher among persons aged 50-64 years (median: 53.4%; range: 27.6%-74.9%)
than among persons aged 18-49 years (median: 27.7%; range: 16.6%-41.1%). For
respondents with diabetes, median influenza coverage was 49.0% and ranged
from 26.5% (Puerto Rico) to 62.4% (South Dakota); the median pneumococcal
coverage was 37.1% and ranged from 19.5% (Puerto Rico) to 58.2% (Montana).
For persons with diabetes, vaccination rates were higher among those aged
50-64 years (for influenza, median: 56.5%; range: 23.7%-73.1% and for pneumococcal,
median: 42.6%; range: 19.7%-68.1%) than among persons aged 18-49 years
(for influenza, median: 37.8%; range: 22.2%-59.9% and for pneumococcal, median:
28.3%; range: 13.3%-56.7%).
BH Bardenheier, MPH, MA, PM Wortley, MD, Immunization Svcs Div; G Euler,
DrPH, Epidemiology and Surveillance Div, National Immunization Program, CDC.
The findings in this report indicate an increase in influenza and pneumococcal
vaccination coverage for the majority of areas from 2002 to 2003 among adults
aged ≥65 years; however, coverage among persons indicated for these vaccinations
remains below the national health objectives for 2010. In addition, almost
half of the states reported >50% influenza coverage levels for participants
aged 18-64 years with diabetes; however, the median coverage level of influenza
vaccination among participants with asthma and the median coverage level of
pneumococcal vaccines among participants with diabetes were below the 2010
target of 60% for noninstitutionalized adults at high risk. Among respondents
with asthma and diabetes, those aged 18-49 years had substantially lower vaccination
coverage than those aged 50-64 years.
Lack of awareness of the need for vaccination is common among adults
aged <65 years with high-risk conditions, such as diabetes or asthma. In
a 2003 survey, approximately 75% of unvaccinated persons aged 18-64 years
with diabetes reported that they were unaware of the need for influenza vaccine
(CDC, unpublished data, 2003). Although use of preventive health services
by adults with diabetes has increased since 1995,3 a substantial
proportion of generalist and subspecialist physicians did not strongly recommend
influenza and pneumococcal vaccinations to their patients who are elderly
or at high risk.4 Low vaccination rates among persons with high-risk
conditions might reflect the challenge of targeting patients for vaccinations
on the basis of high-risk conditions instead of age.1 Although
a majority of patients seen by subspecialists might be those who most need
vaccination, subspecialists might not perceive the provision of preventive
services as their role. Primary care physicians and subspecialists should
work together to ensure that persons at high risk receive appropriate vaccinations.
In addition, strategies to increase awareness among young adults of the need
for vaccinations could be emphasized by diabetes- and asthma-care programs.3,5 The Diabetes Quality Improvement Project, a collaborative effort
between public and private organizations to improve preventive care for persons
with diabetes, has been ongoing since 19956; this effort is one
possible reason for the higher influenza vaccination rates among those with
diabetes compared with those with asthma.
The findings in this report are subject to at least three limitations.
First, vaccination status (influenza and pneumococcal) was based on self-report
and not validated. The validity of self-reported pneumococcal vaccination
is lower than that of influenza vaccination.7 Second, the median
BRFSS response rate (53.2%) in this survey was low. BRFSS results have been
compared with results from the National Health Interview Survey (NHIS), a
household-based, face-to-face interview survey with higher response rates.
Comparisons demonstrate similar trends and subgroup differences; however,
BRFSS vaccination estimates are consistently higher than NHIS estimates.8 Finally, because BRFSS does not systematically assess other medical
conditions for which influenza and pneumococcal vaccines are recommended,
vaccine coverage for all persons with high-risk conditions was not examined.
The variation in influenza and pneumococcal vaccination coverage observed
among areas suggests that vaccination coverage can be improved. Previous studies
have indicated that organizational changes, such as nurse standing orders,
combined with teamwork and collaboration, are effective intervention measures
for increasing adult vaccination services.9 Effective measures
to promote the use of such measures are needed for vaccination rates to increase.
Because of the 2004 influenza vaccine shortage, vaccine providers have
been asked to direct available inactivated influenza vaccine to persons with
chronic conditions, such as diabetes and asthma, and other priority groups.
Further analysis of influenza vaccine coverage data will be needed to assess
the impact of this shortage on influenza vaccine coverage and efforts to redirect
vaccine to persons at greatest risk for influenza complications. Ensuring
adequate amounts of influenza vaccine is critical if vaccination rates of
persons at high risk are to continue improving. Pneumococcal vaccine supplies
appear to be adequate to meet expected demand. Pneumococcal vaccination should
be encouraged for populations at high risk, both to reduce the risk for invasive
pneumococcal disease itself and to reduce complications of influenza infection.
References: 9 available
*Conditions ascertained by BRFSS that are indicated for vaccination
include asthma (indicated for influenza vaccine) and diabetes (indicated for
influenza and pneumococcal vaccines).
Influenza and Pneumococcal Vaccination Coverage Among Persons Aged ≥65 Years and Persons Aged 18-64 Years With Diabetes or Asthma—United States, 2003. JAMA. 2004;292(22):2715-2716. doi:10.1001/jama.292.22.2715